4-(1-(2,3-difluorophenyl)-2-phenylethyl)-1H-imidazole | 1169826-07-6

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: 4-(1-(2,3-difluorophenyl)-2-phenylethyl)-1H-imidazole
• 英文别名: 5-[1-(2,3-difluorophenyl)-2-phenylethyl]-1H-imidazole
• CAS: 1169826-07-6
• 化学式: C₁₇H₁₄F₂N₂
• 分子量: 284.308
• InChiKey: LFDFPONPRMFSSO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  28.7
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• SUBSTITUTED-ARYL-2-PHENYLETHYL-1H-IMIDAZOLE COMPOUNDS AS SUBTYPE SELECTIVE MODULATORS OF ALPHA 2B AND/OR ALPHA 2C ADRENERGIC RECEPTORS
  申请人：Sinha Santosh C.

  公开号：US20090176843A1

  公开（公告）日：2009-07-09

  A compound having selective modulating activity at the alpha 2B and/or alpha 2C adrenergic receptor subtypes is represented by the general Formula 1: wherein n=1-4; X is C or N; R 1 —R 6 can be the same or different and are independently selected from the group consisting of H, C 1-6 alkyl, OCH 3 , OH, F, Cl, Br, CH 2 OH, CH 2 N(R 7 ) 2 , C(O)R 8 , CH 2 CN, CF 3; wherein R 7 is H or C 1-6 alkyl; and R 8 is C 1-6 alkyl or aryl. The compounds of Formula 1 can be incorporated in pharmaceutical compositions and used in methods of treatment of alpha 2 receptor mediated diseases and conditions.

  具有选择性调节α2B和/或α2C肾上腺素受体亚型活性的化合物由通式1表示：其中n=1-4；X为C或N；R1—R6可以相同也可以不同，并且独立地选自H、C1-6烷基、OCH3、OH、F、Cl、Br、CH2OH、CH2N(R7)2、C(O)R8、CH2CN、CF3的群；其中R7为H或C1-6烷基；R8为C1-6烷基或芳基。通式1的化合物可以被纳入药物组成中，并用于治疗α2受体介导的疾病和病况的方法。
• US7902247B2
  申请人：——

  公开号：US7902247B2

  公开（公告）日：2011-03-08
• US8735438B2
  申请人：——

  公开号：US8735438B2

  公开（公告）日：2014-05-27
• [EN] SUBSTITUTED-ARYL-2-PHENYLETHYL-1H-IMIDAZOLE COMPOUNDS AS SUBTYPE SELECTIVE MODULATORS OF ALPHA 2B AND/OR ALPHA 2C ADRENERGIC RECEPTORS<br/>[FR] COMPOSÉS SUBSTITUÉS D'ARYL-2-PHÉNYLÉTHYL-1H-IMIDAZOLE, MODULATEURS SÉLECTIFS DU SOUS-TYPE DES RÉCEPTEURS ADRÉNERGIQUES ALPHA 2B ET/OU ALPHA 2C
  申请人：ALLERGAN INC

  公开号：WO2009089132A1

  公开（公告）日：2009-07-16

  A compound having selective modulating activity at the alpha 2B and/or alpha 2C adrenergic receptor subtypes is represented by the general Formula (1) wherein n=1-4; X is C or N; R1-R6 can be the same or different and are independently selected from the group consisting of H, C1-6 alkyl, OCH3, OH, F, Cl, Br, CH2OH, CH2N(R7)2, C(O)R8, CH2CN, CF3; wherein R7 is H or C1-6 alkyl; and R8 is C1-6 alkyl or aryl. The compounds of Formula (1) can be incorporated in pharmaceutical compositions and used in methods of treatment of alpha 2 receptor mediated diseases and conditions.